Life Sciences Lunch: What Just Happened and What Does It Mean?

The election is OVER!! (Maybe) As of this writing, there’s no way to predict the outcome of the November 3rd U.S. election, but it is safe to say there will be big policy changes coming for the life sciences, no matter who wins the White House. Will science and innovation rule the day or be relegated to the dustbin? Will patients get to keep their health insurance? Will the FDA and CDC learn to get along?

Please join us for an up-to-date rundown on the 2020 election and what it means for biopharma and medical device companies (large and small) going forward. This month, our presenters hail from AdvaMed and the Biotechnology Innovation Organization (BIO) and are THE movers and shakers supporting the industry in Washington, D.C. Whatever will be, will be but it’s always best to be prepared and informed!

Questions? Email Siara Reyes or call 317-231-7211.